Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization
- 1 May 2009
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 72 (1) , 9-17
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumorsJournal of Controlled Release, 2006
- A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimizationInternational Journal of Pharmaceutics, 2006
- The Metabolism of Fatty Alcohols in Lipid Nanoparticles by Alcohol DehydrogenaseDrug Development and Industrial Pharmacy, 2006
- Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial designJournal of Controlled Release, 2006
- Paclitaxel nanoparticles for the potential treatment of brain tumorsJournal of Controlled Release, 2004
- Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid NanoparticlesCritical Reviews™ in Therapeutic Drug Carrier Systems, 2004
- Gadolinium-Loaded Nanoparticles Engineered from Microemulsion TemplatesDrug Development and Industrial Pharmacy, 2002
- Paclitaxel Stability in SolutionAnalytical Chemistry, 1997
- Crystallization tendency and polymorphic transitions in triglyceride nanoparticlesInternational Journal of Pharmaceutics, 1996
- Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugsBiomaterials, 1996